quiverquant

HUTCHMED Announces Positive Phase III SAFFRON Results for ORPATHYS Plus TAGRISSO in MET-Driven EGFR-Mutated Non-Small Cell Lung Cancer

HUTCHMED announced positive results from the global Phase III SAFFRON trial, demonstrating that the combination of ORPATHYS® ...